Who owns SEELOS THERAPEUTICS INC CLASS EQUITY?

Tip: Access positions for across all investors

Analyze quarterly positions in Seelos Therapeutics Inc Class Equity with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Seelos Therapeutics Inc Class Equity stock

Who bought or sold SEELOS THERAPEUTICS INC CLASS EQUITY this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
AdvisorShares Investments 90k $56k 100% Jun 2024
 View chart
Wealth Effects 54k $32k 100% Jun 2024
 View chart
Morgan Stanley 22k $13k 100% Jun 2024
 View chart
Modera Wealth Management 21k $13k 100% Jun 2024
 View chart
Geode Capital Management 13k $7.6k 100% Jun 2024
 View chart
BlackRock 7.0k $4.2k 100% Jun 2024
 View chart
Tower Research Capital 3.9k $2.3k 100% Jun 2024
 View chart
Carmichael Hill & Associates 1.0k $597.000000 100% Jun 2024
 View chart
Jpmorgan Chase & Co 501.00 $501.000000 100% Jun 2024
 View chart
Bank of America Corporation 472.00 $282.020000 100% Jun 2024
 View chart
Group One Trading 216.00 $128.995200 100% Jun 2024
 View chart
Vermillion & White Wealth Management Group 123.00 $73.000500 100% Jun 2024
 View chart
Crewe Advisors 115.00 $69.000000 100% Jun 2024
 View chart
Wells Fargo & Company 41.00 $24.001400 100% Jun 2024
 View chart
Newbridge Financial Services Group 24.00 $13.999200 100% Jun 2024
 View chart
Westside Investment Management 4.00 $2.000000 100% Jun 2024
 View chart
National Bank Of Canada /fi/ 4.00 $2.000000 100% Jun 2024
 View chart
Pnc Financial Services 2.00 $2.000000 100% Jun 2024
 View chart
Bnp Paribas Arbitrage, Snc 1.00 $1.000000 100% Jun 2024
 View chart